Journal Home
Search for

Volume 91, Issue 1, Pages 56-61 (January 2009)


View previous. 11 of 58 View next.

Common 677C→T mutation of the 5,10-methylenetetrahydrofolate reductase gene affects follicular estradiol synthesis

Stephanie Hechta, Roman Pavlika, Peter Lohse, M.D.b, Ulrich Noss, M.D.c, Klaus Friese, M.D.a, Christian J. Thaler, M.D.aCorresponding Author Informationemail address

Received 14 March 2007; received in revised form 5 November 2007; accepted 5 November 2007. published online 13 February 2008.

Objective

To investigate the influence of the 5,10-methylenetetrahydrofolate reductase 677C→T mutation on the E2 synthesis in human granulosa cells (GCs).

Design

In vitro cell culture study.

Setting

Research laboratory of a university hospital.

Patient(s)

Follicular fluids (n = 139) and GCs (n = 66) were obtained from patients undergoing controlled ovarian hyperstimulation for IVF with or without ICSI.

Intervention(s)

Granulosa cells were cultured for a total of 5 days. On day 3, the cells either were stimulated with recombinant (r-) FSH or r-LH (80 IU/L for 48 h) or were sham stimulated.

Main Outcome Measure(s)

Estradiol and protein content were measured in the pooled follicular fluids of each individual. At the end of each GC-culturing period, the concentrations of E2 were measured in the supernatants of triplicate cultures by immunoassays. The 5,10-methylenetetrahydrofolate reductase 677C→T genotype was determined by RFLP analysis.

Result(s)

The E2-protein ratio of homozygous T/T carriers was significantly lower compared with that of homozygous C/C individuals. Furthermore, basal and r-FSH– as well as r-LH–stimulated E2 synthesis of GC obtained from homozygous T/T patients was significantly reduced, compared with GC from heterozygous C/T and homozygous C/C subjects.

Conclusion(s)

Decreased E2 in follicular fluid and decreased E2 synthesis of GC from homozygous T/T individuals suggest that reduced follicular E2 is a result of impaired E2 production of human GC.

a Department of Obstetrics and Gynecology, Division of Endocrinology and Reproductive Medicine, Grosshadern, Ludwig Maximilians-University, Munich, Germany

b Department of Clinical Chemistry, Grosshadern, Ludwig Maximilians-University, Munich, Germany

c Centre for Reproductive Medicine, Munich, Germany

Corresponding Author InformationReprint requests: Christian J. Thaler, M.D., Department of Obstetrics and Gynecology, Division of Endocrinology and Reproductive Medicine, Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, D-81377 Munich, Germany (FAX: 49-89-7095-7588).

 Authors S.H. and R.P. contributed equally to the work and both should be considered to be the first author.

 Supported by the Department of Obstetrics and Gynecology, Grosshadern, Ludwig-Maximilians-University, Munich, Germany.

 Presented at the 56th National Congress of Gynecology and Obstetrics, Berlin, Germany, September 19–22, 2006.

PII: S0015-0282(07)03976-3

doi:10.1016/j.fertnstert.2007.11.011


View previous. 11 of 58 View next.